The Anita Grigoriadis Cancer Bioinformatics group, at KCL, implements analytical approaches to exploit large complex data sets in the study of Breast Cancers
📢the Journal of Pathology has published our work on a multiscale DL framework for immune response in lymph nodes of breast cancer patients. Congratulations to Greg (@Gregoryverg) and Mengyuan (@MengyuanAuuuuuu ) for this excellent work https://t.co/23WgW4odVL #TNBC#AI
Our chief executive, @Michelle_CRUK, sat down with @SciTechgovuk to talk about the latest on cancer diagnostics and treatments, and our transformative research.
Open Doctoral Clinical Fellow position @DinisCalado laboratory at @TheCrick. We are investigating how to identify and kill therapy resistant cancer cells in #lymphoma. Apply by the 15th of November 2024.
More information here: https://t.co/ZhzQyliCIw
People continue to experience long waits for diagnosis and treatment, and there’s an unacceptable postcode lottery for access to treatments services.
With ambition and a dedicated cancer plan, we can screen, diagnose, treat and support everyone affected by breast cancer.
🚨MRC-iCASE PhD studentship available🚨to join my lab at @KingsCollegeLon and study lymph node stroma-immune interactions in lung cancer to improve immunotherapy.
🗓️Closing date Tue 29 October 1PM
@KCL_MRCDTP#MRCDTP25#PhDposition#London#AstraZeneca
https://t.co/0PhkhukBus
Anita Grigoriadis and Laszlo Radvanyi will receive an Early Detection & Diagnosis Primer Award, jointly funded with @OICR_news, to map the retro-transposable element expression in individuals with varying #BreastCancer risk to identify new biomarkers.
@KingsCollegeLon | #CRUKFunded
Today we are publishing evidence from our Institutes to show the impact of changes to the UK immigration system on cancer research.
We call on the new UK Government to reduce costs and review the system so it works for research - to meet their ambitions for health and growthToday we are publishing evidence from our Institutes to show the impact of changes to the UK immigration system on cancer research.
We call on the new UK Government to reduce costs and review the system so it works for research - to meet their ambitions for health and growthToday we are publishing evidence from our Institutes to show the impact of changes to the UK immigration system on cancer research.
We call on the new UK Government to reduce costs and review the system so it works for research - to meet their ambitions for health and growthToday we are publishing evidence from our Institutes to show the impact of changes to the UK immigration system on cancer research.
We call on the new UK Government to reduce costs and review the system so it works for research - to meet their ambitions for health and growthToday we are publishing evidence from our Institutes to show the impact of changes to the UK immigration system on cancer research.
We call on the new UK Government to reduce costs and review the system so it works for research - to meet their ambitions for health and growthToday we are publishing evidence from our Institutes to show the impact of changes to the UK immigration system on cancer research.
We call on the new UK Government to reduce costs and review the system so it works for research - to meet their ambitions for health and growth.
We had such a great time hosting A-level students for a week of research experience as part of the @CRUKCOLcentre and @KCLcancer_pharm STARS widening participation programme. With consent, here is western blotting for cancer chemotherapy! Good luck, all! https://t.co/kGhfZ6P3rK
We’re proud to fund #STARS2024, our major equality, diversity and inclusion initiative for aspiring young scientists.
Read Professor John Marshall’s blog on the aims of the programme: https://t.co/toL86tP1wC
A new paper describes the role of two RNA binding proteins in the development of sarcoma and carcinoma cancers, highlighting the role of RNA binding proteins in cancer research and offering a new avenue for therapeutic targets
Read more ⬇
https://t.co/OK3zUY8FHh
Ahead of the next general election, Dame Deborah James’ father Alistair and the rest of her family have written to political party leaders urging them to back Cancer Research UK’s #CancerManifesto, by committing to a long-term cancer strategy for England, with early diagnosis at its heart 👇
https://t.co/v8o26TaWv4
Signaling axis preserves mitochondrial function and prevents death of IgG1+ B cells as they undergo positive selection, according to a new study. @TheCrick https://t.co/ISPEWL1YOB
We are hiring a Senior Research Fellow in Clinical AI -if you are interested in multimodal data integration, uncertainty quantification, and explainability, join us :) https://t.co/U3PJOGZtgH
If you are enthusiastic about science and enjoy writing and organising researchers :) - please apply --Strategic Research Development Manager - King's College London --https://t.co/X8zkca315X